BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.

BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT)
Listen to this Section


$7.67
-0.5600 ( -6.80% ) 175.0K

BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Market Data


Open $7.67
Previous Close $8.23
Volume 175.0K
Market Cap $659.28M
Day Range $7.67 - $8.26
52 Week Range $7.60 - $14.87
Shares Outstanding 80.11M
Change % -6.80%
Net Change ▼ -0.5600
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2025
CountryUnited States
UnderwriterLeerink Partners, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 12, 2025
10-q Quarterly Reports 82 Nov 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy